Literature DB >> 12719457

Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours.

T Tornóczky1, E Kövér, L Pajor.   

Abstract

AIM: Gastrointestinal stromal tumours (GISTs) are uncommon mesenchymal neoplasms. Some metastasise, whereas others remain asymptomatic for years, but it is difficult to distinguish between them histologically. This report analyses the characteristics of seven metastasising GISTs and compares clinicopathological parameters of the metastatic and non-metastatic groups. METHODS/
RESULTS: Histology revealed typical GIST features with spindle, epithelioid, or mixed appearance. All seven cases were positive for vimentin, five for neurone specific enolase, six for c-kit, four for S-100, three for PGP-9.5, three for CD-34 and synaptophysin, but all were negative for cytokeratin, neurofilament, chromogranin A, and desmin. Four showed a focal reaction for smooth muscle actin. Three of the tumours were GI, and two each were GII and GIII. The Ki-67 index varied from 4% to 44%, the three GI cases had 4%, 10%, and 16%. Tumours from the metastatic GIST group were significantly larger than those from the non-metastatic group.
CONCLUSIONS: Three cases exhibited bland, GI histological features with moderate or low proliferative activity. Among the c-kit positive metastasising stromal tumours, some were low grade, with moderate or low mitotic and Ki-67 indices, emphasising the necessity to develop a reliable grading system for GIST to predict clinical behaviour, the importance of careful analysis of "benign looking" tumours, and the key role of c-kit status in identifying patients who could benefit from treatment with STI-571. Larger tumours had a higher chance of metastasising, and only the size of the primary tumour played a role in predicting metastatic potential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719457      PMCID: PMC1769936          DOI: 10.1136/jcp.56.5.363

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  Gastrointestinal stromal tumours: correlation of immunophenotype with clinicopathological features.

Authors:  P L Newman; C Wadden; C D Fletcher
Journal:  J Pathol       Date:  1991-06       Impact factor: 7.996

Review 2.  Differentiation and risk assessment of gastrointestinal stromal tumors.

Authors:  D W Franquemont
Journal:  Am J Clin Pathol       Date:  1995-01       Impact factor: 2.493

Review 3.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

4.  Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasm.

Authors:  G A Herrera; H Pinto de Moraes; W E Grizzle; S G Han
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

5.  Gastrointestinal stromal tumours: an immunohistochemical study of 165 cases.

Authors:  J Hurlimann; D Gardiol
Journal:  Histopathology       Date:  1991-10       Impact factor: 5.087

6.  Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system.

Authors:  M Trojani; G Contesso; J M Coindre; J Rouesse; N B Bui; A de Mascarel; J F Goussot; M David; F Bonichon; C Lagarde
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

Review 7.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

8.  A flow cytometric, clinical, and histological study of stromal neoplasms of the gastrointestinal tract.

Authors:  P N Cooper; P Quirke; G J Hardy; M F Dixon
Journal:  Am J Surg Pathol       Date:  1992-02       Impact factor: 6.394

9.  Gastrointestinal autonomic nerve tumors. 'Plexosarcomas'.

Authors:  G A Herrera; L Cerezo; J E Jones; J Sack; W E Grizzle; W J Pollack; R L Lott
Journal:  Arch Pathol Lab Med       Date:  1989-08       Impact factor: 5.534

10.  Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors.

Authors:  D W Franquemont; H F Frierson
Journal:  Mod Pathol       Date:  1995-06       Impact factor: 7.842

View more
  3 in total

1.  Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumor.

Authors:  Feng-Yu Liu; Ji-Ping Qi; Feng-Lin Xu; Ai-Ping Wu
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

2.  Gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of 136 cases.

Authors:  Zsolt Orosz; Tamás Tornóczky; Zoltán Sápi
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

3.  Alteration of cellular behavior and response to PI3K pathway inhibition by culture in 3D collagen gels.

Authors:  Brian Fallica; Joseph S Maffei; Shaun Villa; Guy Makin; Muhammad Zaman
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.